Table 1 Program Cost Data. Program cost data derived from Medi-Cal reimbursements or other sources (column 1). All costs given in U.S. dollars, adjusted to year 2004 using the Medical Care component of the U.S. Consumer Price Index (U.S. Bureau of Labor Statistics). Note 1: For each procedure for which Medicare charges were computed, we obtained charges for all nine regions in California for which Medicare calculates a geographic price adjustment factor. We then computed a weighted average based on the year 2004 tuberculosis case count for the nine regions. Note 2: Year 2003 Medicare Part B average national allowed charges (BESS) Note 3: Assuming a standard regimen of isoniazid, pyrazinamide, rifampin and ethambutol for two months, followed by isoniazid and rifampin for four months, assuming a 65 kg adult. Note 4: weighted average of the average daily hospitalization cost for Los Angeles, San Diego, San Francisco [58,59], converted to 2004 dollars; weights derived from cases reported in 1995 [60] (during the CDC Cost of Hospitalization Study). Note 5: Inflated to 2004 dollars by the medical Consumer Price Index. Note 6: These items inflated using the all-items Consumer Price Index.
From: Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants
Variable | Cost | Source |
|---|---|---|
New patient doctor visit | 111.50 | Medicare, 2004, Note 1 |
Established patient visit | 61.25 | Medicare, 2004, Note 1 |
Tuberculin skin test | 11.78 | Medicare, 2004, Note 1 |
Initial chest X-ray | 39.68 | Medicare, 2004, Note 1 |
Sputum collection | 17.80 | Medicare, 2004, Note 1 |
Specimen concentration | 9.33 | Medicare Part B, Note 2 |
AFB smear | 7.50 | Medicare Part B, Note 2 |
Sputum culture | 14.42 | Medicare Part B, Note 2 |
Sensitivity testing | 7.38 | Medicare Part B, Note 2 |
Mycobacterial identification | 15.29 | Medicare Part B, Note 2 |
Isoniazid, 100 tablets | 8.90 | Medicaid Federal Upper Limit price |
Chemotherapy for active TB | 1118 | Drug prices Red Book, 2004; ATS recommendations; Note 3 |
Nurse assessment, 1/4 hr | 8.40 | Medi-Cal |
Liver function tests | 11.42 | Medicare Part B, Note 2 |
TB hospitalization episode | 25 834 | Note 4; based on CDC unpublished data |
Hepatitis hospital stay | 10 662 | Note 5; [61] |
Complete blood count | 9.04 | Medicare Part B, Note 2 |
Renal function panel | 12.13 | Medicare Part B, Note 2 |
Directly observed therapy (DOT) | 19.23 | Medi-Cal |
Disease control investigation | 387.02 | [51,52]; Appendix |
Letter mailed | 10.80 | [42]; Note 6 |
Phone call (community worker) | 13.24 | [42]; Note 6 |
Home visit (community worker) | 39.57 | [42]; Note 6 |